Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
11.85 EUR | +1.28% | -0.84% | -7.06% |
Mar. 14 | Hyloris Pharmaceuticals SA Provides Earnings Guidance for 2024 | CI |
Mar. 14 | Transcript : Hyloris Pharmaceuticals SA, 2023 Earnings Call, Mar 14, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-7.06% | 351M | |
+27.92% | 672B | |
+27.04% | 570B | |
-4.59% | 360B | |
+16.38% | 321B | |
+9.39% | 300B | |
+7.38% | 217B | |
+6.04% | 199B | |
-8.83% | 204B | |
-8.58% | 149B |
- Stock Market
- Equities
- HYL Stock
- News Hyloris Pharmaceuticals SA
- Hyloris Post-Operative Pain Treatment's New Drug Application Gets US FDA Acceptance